(Q43040011)

12 November 2017

Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile (English)

1 reference

12 November 2017

1 reference

1

Huub C Gelderblom

1 reference

12 November 2017

Laurens E J Nijhuis

2

1 reference

12 November 2017

Esther C de Jong

3

1 reference

12 November 2017

Anje A te Velde

4

1 reference

12 November 2017

Dasja Pajkrt

5

1 reference

12 November 2017

Henk W Reesink

6

1 reference

12 November 2017

Marcel G H M Beld

7

1 reference

12 November 2017

Sander J H van Deventer

8

1 reference

12 November 2017

Peter L M Jansen

9

1 reference

12 November 2017

1 September 2007

1 reference

12 November 2017

1 reference

12 November 2017

27

1 reference

12 November 2017

944-953

1 reference

12 November 2017

7

1 reference

Hepatitis C virus infection

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

T cells and viral persistence: lessons from diverse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Evasion of intracellular host defence by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Acute hepatitis C: diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Dendritic cells: immunobiology and cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

The first 1000 dendritic cell vaccinees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Dendritic cell susceptibility to hepatitis C virus genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Langerhans cells arise from monocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Immune responses of liver-infiltrating lymphocytes and peripheral blood mononuclear cells to hepatitis C virus core and NS3 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01507.X

10.1111/J.1478-3231.2007.01507.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference